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Tabel CHNS 
Releaseprofiel: MA5-1b en MA20-1b 
±1650 cm-1: Amide I (C=O) 
±1550 cm-1: Amide II (N-H) 
Sample qe (mgIBU/g) qe (mgIBU/m2) 
SBA-15 103,06 0,159 
MA5 109,75 0,201 
MA10 81,28 0,238 
MA20 83,95 0,303 







Sample SBET (m2/g) Vp (mL/g) dp (nm) 
MA5 545 0,82 6,8 
MA10 341 0,53 5,2 
MA20 276 0,41 5,0 
MA30 176 0,26 / 
MA40 102 0,22 / 
mMA10 621 0,91 6,8 
Table 2: Surface area (SBET), total pore volume 
(Vp) and pore size (dp) of (m)MA-PMOs. dp for 
MA30 and MA40 is indeterminable due to lack of 
ordering. 
Fig. 4: N2 sorption isotherm of a typical MA-PMO 
(MA10) with pore size distribution (inset). H1 type 
IV hysteresis is clearly distinguished.  
Fig. 1: DRIFT spectra 
of (m)MA-PMOs with 
different functional 
loading. For clarity 
the intensity of (b), 
region of organic 
f u n c t i o n a l i t y, i s 
enhanced compared 
to (a), region of Si-O 
s t r e t c h .  A m i d e 
v i b r a t i o n s 
(highlighted) and C-H 
stretch (ν~2950 cm-1) 
confirm the presence 
of (m)MA moieties in 
the PMO-materials. 
 
Table 1: CHNS determined 
(m)MA functional loading 
Acetone 
Scheme 1: Schotten-Baumann reaction of (3-aminopropyltriethoxy)silane 2a and (N-methyl 3-aminopropyltrimethoxy)silane 2b with 
malonylchloride 1. Next, the novel silsesquioxane PMO precursors are used to obtain an extensive range of 2D hexagonal PMOs with 
different functional loading by co-condensation with tetraethyl orthosilicate (TEOS) in a typical PMO synthesis (acidic medium, P123, 
KCl).  
Synthesis and analysis of (methyl)malonamide-PMOs 
Controlled drug release gained a sharply increasing interest over recent years. Multiple materials have been screened as possible drug carriers, ranging from biodegradable polymers 
to hydroxyapatite[1]. Periodic Mesoporous Organosilicas are valuable alternatives as they possess a high chemical and thermal stability combined with a biocompatible nature[2]. 
Furthermore, their large internal surface area permits a high drug loading. Careful selection of the organic ‘bridged’ functionality allows a controlled release with respect to external 
stimuli, such as pH or temperature, of the drugs which are adsorbed via weak and reversible interactions, e.g. H-bonding and hydrophobic-phobic interaction[3]. In this contribution 
a novel malonamide (MA-PMO) and a methyl-malonamide PMO (mMA-PMO) bearing a high amount of H-bond donors and acceptors is developed and thoroughly characterised. 













Fig. 2: XRD patterns 
showing P6mm 2D 
hexagonal ordering 
fo r MA5, MA10, 
MA20 and mMA10. 
This ordering is lost 
for MA30 and MA40. 
F i g .  3 :  S E M 
images of (A) MA5 
and (B) MA20. 
Respectively rod-
like and irregular 
shaped particles 
with similar size 
are found 
Adsorption experiment 
Table 3: Ibuprofen loading at adsorption equilibrium (qe) in mgIBU/g of 
MA-PMO and corrected for the surface area (SBET) in mgIBU/m2. 




Scheme 2: Overview of Ibuprofen adsorption on malonamide 
functionalized PMO materials and controlled release in a phosphate 
buffer solution (PBS) at pH 7,4, mediated by H-bonding interactions 
(dashed) and/or hydrophobic-phobic interactions 
Release experiment 
Fig. 5: Ibuprofen 
release profiles of 
IBU-MA5 and IBU-
MA20. Control led 
drug release was 
found during a long 
period (10-12h), with 
high amounts of IBU 
released. A lower 
drug release rate is 
observed for higher 
M A - f u n c t i o n a l 
l o a d i n g ,  w h i c h 
implies a tunable 
release rate. The 
longer retention of 
IBU in the MA20-
PMO can be ascribed 
to more interactions 
between IBU and the 
PMO drug carrier.  
Tunable drug release rate by varying 
malonamide functional loading 
Two new well-ordered malonamide-type PMOs are developed, showing high porosity and large pore sizes. A malonamide PMO (MA-PMO) is shown promising for controlled drug 
release as the high functional loading leads to large Ibuprofen adsorption via H-bonding and hydrophobic interactions. As the functional loading of the drug carrying PMO is 
increased, intrinsically more Ibuprofen is adsorbed. Furthermore, high amounts of drug are released in a controlled, linear fashion over a long timespan in a phosphate buffer 
solution (pH 7,4) at body temperature. Most interestingly, the rate of drug release is tunable by varying the malonamide functional loading. The influence of H-bonding 
interactions, which possibly give rise to a longer retention of Ibuprofen, can be investigated further by experiments with methyl-malonamide PMOs (mMA-PMOs). Also, these new 
drug carriers may be employed in the controlled release of 5-fluorouracil (5-FU), an anti-cancer agent, or they can even be used as a combined pH-triggered release system of 
both IBU and 5-FU [4]. 
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